Company Filing History:
Years Active: 2019-2022
Title: **Seongsik Yun: A Pioneer in Peptide-Based Agonists**
Introduction
Seongsik Yun, an innovative inventor based in Daejeon, South Korea, has made significant contributions to the field of biotechnology. With two patents to his name, Yun has focused on developing peptide-based agonists that show promise for treating various medical conditions. His work is particularly noteworthy for its potential impact on physiological functions in humans.
Latest Patents
One of his latest patents is titled "Agonist of spexin-based galanin type 2 receptor and use thereof." This invention pertains to spexin-based agonists that are specific for the galanin receptor type 2. More specifically, it provides peptide-based agonists with high specificity for this receptor and improved stability. The significance of this invention lies in its applications for regulating vital physiological functions such as food intake, anxiety, emotion, and addiction, which are influenced by the galanin receptor type 2. These peptide-based agonists can effectively suppress appetite, aid in recovery from anxiety disorders, and reduce pleasure addiction. As a result, they hold potential to prevent or treat diseases mediated by the galanin receptor type 2.
Career Highlights
Seongsik Yun works at Neuracle Science Co., Ltd., a company dedicated to advancing scientific research and innovation in neuroscience. His expertise in peptide-based technologies plays a critical role in the company's mission to develop effective therapeutic solutions.
Collaborations
In his research endeavors, Yun collaborates with esteemed colleagues, including Jae Young Seong and Jong-Ik Hwang. These partnerships enhance the research culture at Neuracle Science Co., Ltd., fostering innovation and breakthroughs in the field of biotechnology.
Conclusion
Seongsik Yun is a noteworthy inventor whose work in peptide-based agonists could revolutionize treatments for various receptor-mediated conditions. His dedication to innovation, combined with the collaborative spirit at Neuracle Science Co., Ltd., positions him as a leader in the biotechnology sector. As research progresses, it will be exciting to see the impact of his patents on the medical community and beyond.